The Taipei Medical University (TMU) established the TMU-JIRB in accordance with ICH-GCP E6, the Medical Care Act, the Human Research Act as well as Regulations Governing the Organization and Operational Management of the Institutional Review Board for Human Subject Research to protect human trial/study participants’ right and welfare and to encourage research and development in TMU. All 4 IRBs (TMU-JIRB、TMU-JIRB A、TMU-JIRB B、TMU-JIRB C) are recognized by domestic and international accreditation programs.
The responsibilities of independent IRBs are as below:
● To establish ethical policies and regulations for the clinical study approval process at TMU.
● To set up the definition, content, range of review of human trial/study.
● To review and give recommendations for human trials/studies.
● To evaluate the safety, feasibility of human trials/studies and monitor trials/studies
● Responsible for human participants’ protection in trials/studies.
● Other evaluations or special concerns in human trials/studies.
The JIRB Administration Section is established under the Office of Human Research and is primarily responsible for the review system, standard operating procedures, and administrative support for the Joint Institutional Review Board of Taipei Medical University and its affiliated hospitals (Taipei Medical University – Joint Institutional Review Board, TMU-JIRB), ensuring that the TMU-JIRB conducts independent and specialized reviews.
Contact
If you have any questions about participant rights and ethical issues, please contact TMU-JIRB, we will help you.
Tel: 02-6620-2589 #15313
Fax: 02-2739-1321
E-mail: tmujirb@gmail.com
Address: 3F., Biomedical Technology Building, No. 301, Yuantong Rd., Zhonghe Dist., New Taipei City 235, Taiwan (R.O.C.) (Shuangho Campus)
